<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="104117">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01787461</url>
  </required_header>
  <id_info>
    <org_study_id>B5271003</org_study_id>
    <nct_id>NCT01787461</nct_id>
  </id_info>
  <brief_title>A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure</brief_title>
  <official_title>Randomized, Double-blind, Placebo-Controlled Trial Assessing The Effects of an Oral Dietary Supplement Containing Marine and Plant Extracts on Overall Facial Skin Appearance Among Healthy Adult Women With Photo-aged Skin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pfizer</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study hypothesis is that Imedeen will show effects on skin health, when compared to
      placebo over a 6 month intervention period with respect to changes in skin appearance, skin
      density, moisture, and in fine lines and wrinkles.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">March 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Investigator's Global Assessment (IGA) of subject's overall facial appearance at Week 24</measure>
    <time_frame>Week 24</time_frame>
    <safety_issue>No</safety_issue>
    <description>Investigator will examine changes in the overall facial appearance assessing fine lines and wrinkles of the periocular and perioral areas, dark circles, mottled hyperpigmentation, sallowness and roughness</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Photograph assessment of the subject's overall facial appearance at Week 24 as compared to Baseline by an Independent Panel Review Committee (IPRC) using an improvement scale</measure>
    <time_frame>Baseline and Week 24</time_frame>
    <safety_issue>No</safety_issue>
    <description>Photograph assessment of the subject's overall facial appearance at Week 24 as compared to Baseline by an Independent Panel Review Committee (IPRC) using an improvement scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigator's Global Assessment of subject's overall facial appearance at Week 12</measure>
    <time_frame>Week 12</time_frame>
    <safety_issue>No</safety_issue>
    <description>Investigator's Global Assessment of subject's overall facial appearance at Week 12 assessing fine lines and wrinkles of the periocular and perioral areas, dark circles, mottled hyperpigmentation, sallowness and roughness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigator's assessment of face, decolletage, and back of hands on photoaging parameters using a  numerical severity scale</measure>
    <time_frame>Weeks 12 and 24</time_frame>
    <safety_issue>No</safety_issue>
    <description>Investigator's assessment of face, decolletage, and back of hands</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneometry (hydration) Trans-Epidermal Water Loss  Ultrasound (skin density)</measure>
    <time_frame>Week 6, 12, 18, 24</time_frame>
    <safety_issue>No</safety_issue>
    <description>Corneometry (hydration) Trans-Epidermal Water Loss Ultrasound (skin density)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">194</enrollment>
  <condition>Photodamaged Skin</condition>
  <arm_group>
    <arm_group_label>Imedeen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Imedeen is the study product</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Imedeen</intervention_name>
    <description>Two tablets per day for 6 months</description>
    <arm_group_label>Imedeen</arm_group_label>
    <other_name>Imedeen Time Perfection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Two tablets per day for 6 months</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        In general good health and have no contraindications to the study product; Have
        Fitzpatrick Skin Type I-IV as determined by a trained evaluator. Have Glogau
        Classification of Photoaging of II or III as determined by the investigator.

        Exclusion Criteria:

        Use of any dietary supplement, over-the-counter or prescription product with the
        indication of improving the appearance or condition of the skin within one month of
        baseline.

        History of or current disease or condition of the skin that the investigator deems
        inappropriate for participation (eg, atopic skin, facial scars, psoriasis, eczema, other
        scaly inflammatory diseases).

        Subjects who have had a facial cosmetic procedures (eg, fillers, toxins, facial peel) or
        invasive surgical procedures (eg, laser treatment or face lift) or other facial treatments
        by a physician or skin care professional within the last 6 to 9 months from baseline
        (pending procedure type) or plan to have a treatment during the study.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pfizer CT.gov Call Center</last_name>
    <role>Study Director</role>
    <affiliation>Pfizer</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33137</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Fair Lawn</city>
        <state>New Jersey</state>
        <zip>07410</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Lynchburg</city>
        <state>Virginia</state>
        <zip>24501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Virginia Beach</city>
        <state>Virginia</state>
        <zip>23462</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B5271003&amp;StudyName=A%20study%20to%20assess%20the%20effects%20of%20an%20oral%20dietary%20supplement%20on%20overall%20facial%20appearance%20among%20healthy%20adult%20women%20with%20existing%20ski</url>
    <description>To obtain contact information for a study center near you, click here.</description>
  </link>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 11, 2014</lastchanged_date>
  <firstreceived_date>December 5, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Trial assessing effects of an oral dietary supplement on overall facial appearance among healthy women with photodamaged skin.</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Facies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
